21 May 2009
Anaemia and erythrocytosis after kidney transplantation and 5-year graft survival
J Pinocy-Mańdok, J Chudek, A Kolonko, A WiecekAnn Transplant 2009; 14(1): 51-51 :: ID: 880387
Abstract
Background: Both anaemia and erythrocytosis frequently occur after kidney
transplantation (KTx). However their infl uence on cardiovascular complications and the risk of kidney graft loss is not well documented. The aim of this study was to analyze the influence of both anaemia and erythrocytosis on kidney graft function and patients outcome in a long-term follow-up after kidney transplantation.
Material/Methods: Two hundred ninety nine consecutive patients with at least 12-month post successful kidney transplantation were enrolled in this study. 90.1% of analysed patients had completed a 5-year follow-up period. Anaemia occurred in 29.5% of patients (in 16.1% Hb <11.0g/dl), while erythrocytosis in 19.1% of patients (including 9.0% with Ht >55%). We have analysed the graft function 12 months after KTx and the impact of anaemia or erythrocytosis on 5-year risk of death and graft loss.
Results: In 58% of anaemic patients low haemoglobin concentration did not
reach normal range in the whole observation time after KTx. The mean eGFR-
MDRD 12 months post KTx was significantly lower in patients with anaemia
(44.9±18.8 ml/min vs. 52.9±17.0 ml/min;p=0.01). Better 12-month graft function was observed in patients with erythrocytosis (59.0±18.4 ml/min). Anaemia but not erythrocytosis was associated with the increased risk of graft loss [RR=3.79 (1.97-7.29); p<0.001]. The risk of death was similar in all subgroups.
Conclusions: Anaemia after KTx is associated with a worse kidney graft function and is a strong predictor of graft loss. Erythrocytosis occurs in patients with excellent kidney graft function; nonetheless it did not increase the risk of graft loss or death when properly treated with phlebotomy.
Keywords: Kidney Transplantation
In Press
08 Mar 2024 : Original article
Association of Coronary Calcium Score on Cardiac PET During Pre-Kidney Transplant Assessment with Persisten...Ann Transplant In Press; DOI: 10.12659/AOT.943532
14 Mar 2024 : Original article
Impact of Blood Products Transfusion on Patients in the Immediate Post-Lung Transplant Period: A Cohort StudyAnn Transplant In Press; DOI: 10.12659/AOT.943652
14 Mar 2024 : Case report
Treatment of Cavernous Transformation of Portal Vein Caused by Hepatic Cystic Echinococcosis Using Ex Vivo ...Ann Transplant In Press; DOI: 10.12659/AOT.942358
15 Mar 2024 : Review article
Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighti...Ann Transplant In Press; DOI: 10.12659/AOT.941185
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860